Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. (flaxseed) in vivo.
Study Design
- Studientyp
- Other
- Population
- DNBS-induced Crohn's disease BALB/c mouse model
- Intervention
- Intestinal anti-inflammatory, histopathologic and anti-oxidative regulatory effects of total alkaloids extract from Linum usitatissimum L. (flaxseed) in vivo. 50, 100, and 200 mg/kg oral
- Vergleichsgruppe
- Dexamethasone 2.4 mg/kg; DNBS colitis model vs healthy
- Primärer Endpunkt
- Colonic inflammation markers (MPO, NO, MDA, CAT, GSH)
- Wirkungsrichtung
- Positive
- Verzerrungsrisiko
- Unclear
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Linum usitatissimum L., commonly known as flaxseed, is a perennial herb in the Lineaceae family that has been traditionally used to manage gastrointestinal disorders and diarrhea. The health benefits and medicinal applications of flaxseed can be attributed to the presence of some beneficial compounds, such as omega-3 fatty acids, tocopherol, cyclic peptides, alkaloids, mucilage, and phenylpropanoids. AIM OF THE STUDY: This investigation explored the potential anti-inflammatory and antioxidant properties of the total alkaloid extract of Linum usitatissimum L. seeds (ALU) in a model of Crohn's disease induced by 2,4-dinitrobenzenesulfonic acid (DNBS) in BALB/c mice. MATERIALS AND METHODS: ALU fraction was chemically characterized by liquid chromatography combined with electrospray ionization mass spectrometry (LC-ESI-MS/MS). Six groups of mice (n = 6) were divided as follow: healthy group, colitic control, Dexamethasone treated-group (2.4 mg/kg) and three group for ALU treatment (50, 100 and 200 mg/kg). Intrarectal instillation of DNBS (250 mg/kg) induced colonic inflammation accompanied by body weight loss, colonic architecture modification, inflammatory cells infiltration and excessive inflammatory markers production. Tissues sample were used to assess the histological damages and eventual goblet cells loss (H & E and PAS staining) and to evaluate inflammatory and oxidative statute (MPO, NO, H2O2, MDA, CAT and GSH). RESULTS: The phytochemical analysis of total alkaloid fraction of LU revealed the presence of 10 compounds. Oral administration of ALU (50, 100, and 200 mg/kg) significantly ameliorated DNBS-induced colitis in mice in a dose-dependent manner. ALU treatment mitigated body weight loss, reduced the weight/length (W/L) ratio, and improved clinical outcomes, including diarrhea and food intake. Histological analyses revealed that ALU treatment, preserved colonic architecture, enhanced goblet cell numbers, reduced neutrophil infiltration, and minimised mucosal damage, with a comparable effect to dexamethasone treatment. ALU also promoted mucosal healing and neutral mucin retention. Furthermore, ALU exerted potent anti-inflammatory and antioxidant effects by modulating key markers such as MPO, NO, H2O2, MDA, CAT, and GSH, supporting its protective role against colonic inflammation. CONCLUSION: These findings indicate that alkaloid fraction extracted from Linum usitatissimum L. have strong anti-inflammatory and antioxidant properties in a DNBS-induced colitis model in BALB/c mice.
Zusammenfassung
Findings indicate that alkaloid fraction extracted from Linum usitatissimum L. seeds have strong anti- inflammatory and antioxidant properties in a DNBS-induced colitis model in BALB/c mice, supporting its protective role against colonic inflammation.
Used In Evidence Reviews
Similar Papers
The American journal of clinical nutrition · 1991
Omega-3 fatty acids in health and disease and in growth and development.
Journal of the American College of Nutrition · 2002
Omega-3 fatty acids in inflammation and autoimmune diseases.
The American journal of gastroenterology · 2011
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
The American journal of gastroenterology · 2007
Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children.
The American journal of gastroenterology · 1992
Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
The Cochrane database of systematic reviews · 2009